カテゴリー： 世界, 部品/材料, QYResearch

ビスモデギブの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Vismodegib Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX02855）・商品コード：QY22JLX02855
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：88
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥735,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,102,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,470,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、ビスモデギブのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にビスモデギブの世界市場のxxx％を占める「純度≥99%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医薬品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
ビスモデギブの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのビスモデギブ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ビスモデギブのグローバル主要企業には、Fermion、Roche、Symbio Generrics、Hetero、Southeast Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ビスモデギブ市場は、種類と用途によって区分されます。世界のビスモデギブ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99%、純度≥99.5%以上

【用途別セグメント】
医薬品、研究用試薬、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ビスモデギブ製品概要
- 種類別市場（純度≥99%、純度≥99.5%以上）
- 用途別市場（医薬品、研究用試薬、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のビスモデギブ販売量予測2017-2028
- 世界のビスモデギブ売上予測2017-2028
- ビスモデギブの地域別販売量
- ビスモデギブの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ビスモデギブ販売量
- 主要メーカー別ビスモデギブ売上
- 主要メーカー別ビスモデギブ価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度≥99%、純度≥99.5%以上）
- ビスモデギブの種類別販売量
- ビスモデギブの種類別売上
- ビスモデギブの種類別価格
・用途別市場規模（医薬品、研究用試薬、その他）
- ビスモデギブの用途別販売量
- ビスモデギブの用途別売上
- ビスモデギブの用途別価格
・北米市場
- 北米のビスモデギブ市場規模（種類別、用途別）
- 主要国別のビスモデギブ市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのビスモデギブ市場規模（種類別、用途別）
- 主要国別のビスモデギブ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のビスモデギブ市場規模（種類別、用途別）
- 主要国別のビスモデギブ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のビスモデギブ市場規模（種類別、用途別）
- 主要国別のビスモデギブ市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのビスモデギブ市場規模（種類別、用途別）
- 主要国別のビスモデギブ市場規模（トルコ、サウジアラビア）
・企業情報
Fermion、Roche、Symbio Generrics、Hetero、Southeast Pharmaceuticals
・産業チェーン及び販売チャネル分析
- ビスモデギブの産業チェーン分析
- ビスモデギブの原材料
- ビスモデギブの生産プロセス
- ビスモデギブの販売及びマーケティング
- ビスモデギブの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ビスモデギブの産業動向
- ビスモデギブのマーケットドライバー
- ビスモデギブの課題
- ビスモデギブの阻害要因
・主な調査結果

Market Analysis and Insights: Global Vismodegib Market
Due to the COVID-19 pandemic, the global Vismodegib market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Vismodegib global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
China Vismodegib market size is valued at US$ million in 2021, while the US and Europe Vismodegib are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vismodegib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Vismodegib include Fermion, Roche, Symbio Generrics, Hetero and Southeast Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Vismodegib capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Vismodegib by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Vismodegib Scope and Segment
Vismodegib market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Vismodegib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Pharmaceutical
Research Reagents
Other
By Company
Fermion
Roche
Symbio Generrics
Hetero
Southeast Pharmaceuticals
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Vismodegib Product Introduction
1.2 Market by Type
1.2.1 Global Vismodegib Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Vismodegib Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Research Reagents
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Vismodegib Production
2.1 Global Vismodegib Production Capacity (2017-2028)
2.2 Global Vismodegib Production by Region: 2017 VS 2021 VS 2028
2.3 Global Vismodegib Production by Region
2.3.1 Global Vismodegib Historic Production by Region (2017-2022)
2.3.2 Global Vismodegib Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Vismodegib Sales in Volume & Value Estimates and Forecasts
3.1 Global Vismodegib Sales Estimates and Forecasts 2017-2028
3.2 Global Vismodegib Revenue Estimates and Forecasts 2017-2028
3.3 Global Vismodegib Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Vismodegib Sales by Region
3.4.1 Global Vismodegib Sales by Region (2017-2022)
3.4.2 Global Sales Vismodegib by Region (2023-2028)
3.5 Global Vismodegib Revenue by Region
3.5.1 Global Vismodegib Revenue by Region (2017-2022)
3.5.2 Global Vismodegib Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Vismodegib Production Capacity by Manufacturers
4.2 Global Vismodegib Sales by Manufacturers
4.2.1 Global Vismodegib Sales by Manufacturers (2017-2022)
4.2.2 Global Vismodegib Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Vismodegib in 2021
4.3 Global Vismodegib Revenue by Manufacturers
4.3.1 Global Vismodegib Revenue by Manufacturers (2017-2022)
4.3.2 Global Vismodegib Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Vismodegib Revenue in 2021
4.4 Global Vismodegib Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Vismodegib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Vismodegib Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Vismodegib Sales by Type
5.1.1 Global Vismodegib Historical Sales by Type (2017-2022)
5.1.2 Global Vismodegib Forecasted Sales by Type (2023-2028)
5.1.3 Global Vismodegib Sales Market Share by Type (2017-2028)
5.2 Global Vismodegib Revenue by Type
5.2.1 Global Vismodegib Historical Revenue by Type (2017-2022)
5.2.2 Global Vismodegib Forecasted Revenue by Type (2023-2028)
5.2.3 Global Vismodegib Revenue Market Share by Type (2017-2028)
5.3 Global Vismodegib Price by Type
5.3.1 Global Vismodegib Price by Type (2017-2022)
5.3.2 Global Vismodegib Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Vismodegib Sales by Application
6.1.1 Global Vismodegib Historical Sales by Application (2017-2022)
6.1.2 Global Vismodegib Forecasted Sales by Application (2023-2028)
6.1.3 Global Vismodegib Sales Market Share by Application (2017-2028)
6.2 Global Vismodegib Revenue by Application
6.2.1 Global Vismodegib Historical Revenue by Application (2017-2022)
6.2.2 Global Vismodegib Forecasted Revenue by Application (2023-2028)
6.2.3 Global Vismodegib Revenue Market Share by Application (2017-2028)
6.3 Global Vismodegib Price by Application
6.3.1 Global Vismodegib Price by Application (2017-2022)
6.3.2 Global Vismodegib Price Forecast by Application (2023-2028)
7 North America
7.1 North America Vismodegib Market Size by Type
7.1.1 North America Vismodegib Sales by Type (2017-2028)
7.1.2 North America Vismodegib Revenue by Type (2017-2028)
7.2 North America Vismodegib Market Size by Application
7.2.1 North America Vismodegib Sales by Application (2017-2028)
7.2.2 North America Vismodegib Revenue by Application (2017-2028)
7.3 North America Vismodegib Sales by Country
7.3.1 North America Vismodegib Sales by Country (2017-2028)
7.3.2 North America Vismodegib Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Vismodegib Market Size by Type
8.1.1 Europe Vismodegib Sales by Type (2017-2028)
8.1.2 Europe Vismodegib Revenue by Type (2017-2028)
8.2 Europe Vismodegib Market Size by Application
8.2.1 Europe Vismodegib Sales by Application (2017-2028)
8.2.2 Europe Vismodegib Revenue by Application (2017-2028)
8.3 Europe Vismodegib Sales by Country
8.3.1 Europe Vismodegib Sales by Country (2017-2028)
8.3.2 Europe Vismodegib Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Vismodegib Market Size by Type
9.1.1 Asia Pacific Vismodegib Sales by Type (2017-2028)
9.1.2 Asia Pacific Vismodegib Revenue by Type (2017-2028)
9.2 Asia Pacific Vismodegib Market Size by Application
9.2.1 Asia Pacific Vismodegib Sales by Application (2017-2028)
9.2.2 Asia Pacific Vismodegib Revenue by Application (2017-2028)
9.3 Asia Pacific Vismodegib Sales by Region
9.3.1 Asia Pacific Vismodegib Sales by Region (2017-2028)
9.3.2 Asia Pacific Vismodegib Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Vismodegib Market Size by Type
10.1.1 Latin America Vismodegib Sales by Type (2017-2028)
10.1.2 Latin America Vismodegib Revenue by Type (2017-2028)
10.2 Latin America Vismodegib Market Size by Application
10.2.1 Latin America Vismodegib Sales by Application (2017-2028)
10.2.2 Latin America Vismodegib Revenue by Application (2017-2028)
10.3 Latin America Vismodegib Sales by Country
10.3.1 Latin America Vismodegib Sales by Country (2017-2028)
10.3.2 Latin America Vismodegib Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Vismodegib Market Size by Type
11.1.1 Middle East and Africa Vismodegib Sales by Type (2017-2028)
11.1.2 Middle East and Africa Vismodegib Revenue by Type (2017-2028)
11.2 Middle East and Africa Vismodegib Market Size by Application
11.2.1 Middle East and Africa Vismodegib Sales by Application (2017-2028)
11.2.2 Middle East and Africa Vismodegib Revenue by Application (2017-2028)
11.3 Middle East and Africa Vismodegib Sales by Country
11.3.1 Middle East and Africa Vismodegib Sales by Country (2017-2028)
11.3.2 Middle East and Africa Vismodegib Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Fermion
12.1.1 Fermion Corporation Information
12.1.2 Fermion Overview
12.1.3 Fermion Vismodegib Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Fermion Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Fermion Recent Developments
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Overview
12.2.3 Roche Vismodegib Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Roche Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Roche Recent Developments
12.3 Symbio Generrics
12.3.1 Symbio Generrics Corporation Information
12.3.2 Symbio Generrics Overview
12.3.3 Symbio Generrics Vismodegib Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Symbio Generrics Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Symbio Generrics Recent Developments
12.4 Hetero
12.4.1 Hetero Corporation Information
12.4.2 Hetero Overview
12.4.3 Hetero Vismodegib Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Hetero Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hetero Recent Developments
12.5 Southeast Pharmaceuticals
12.5.1 Southeast Pharmaceuticals Corporation Information
12.5.2 Southeast Pharmaceuticals Overview
12.5.3 Southeast Pharmaceuticals Vismodegib Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Southeast Pharmaceuticals Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Southeast Pharmaceuticals Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Vismodegib Industry Chain Analysis
13.2 Vismodegib Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Vismodegib Production Mode & Process
13.4 Vismodegib Sales and Marketing
13.4.1 Vismodegib Sales Channels
13.4.2 Vismodegib Distributors
13.5 Vismodegib Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Vismodegib Industry Trends
14.2 Vismodegib Market Drivers
14.3 Vismodegib Market Challenges
14.4 Vismodegib Market Restraints
15 Key Finding in The Global Vismodegib Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Vismodegib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥99%
Table 3. Major Manufacturers of Purity ≥99.5%
Table 4. Global Vismodegib Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Vismodegib Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Vismodegib Production by Region (2017-2022) & (Tons)
Table 7. Global Vismodegib Production Market Share by Region (2017-2022)
Table 8. Global Vismodegib Production by Region (2023-2028) & (Tons)
Table 9. Global Vismodegib Production Market Share by Region (2023-2028)
Table 10. Global Vismodegib Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Vismodegib Sales by Region (2017-2022) & (Tons)
Table 12. Global Vismodegib Sales Market Share by Region (2017-2022)
Table 13. Global Vismodegib Sales by Region (2023-2028) & (Tons)
Table 14. Global Vismodegib Sales Market Share by Region (2023-2028)
Table 15. Global Vismodegib Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Vismodegib Revenue Market Share by Region (2017-2022)
Table 17. Global Vismodegib Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Vismodegib Revenue Market Share by Region (2023-2028)
Table 19. Global Vismodegib Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Vismodegib Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Vismodegib Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Vismodegib Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Vismodegib Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Vismodegib Revenue Share by Manufacturers (2017-2022)
Table 25. Vismodegib Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Vismodegib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Vismodegib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vismodegib as of 2021)
Table 28. Vismodegib Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Vismodegib Product Offered
Table 30. Date of Manufacturers Enter into Vismodegib Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Vismodegib Sales by Type (2017-2022) & (Tons)
Table 33. Global Vismodegib Sales by Type (2023-2028) & (Tons)
Table 34. Global Vismodegib Sales Share by Type (2017-2022)
Table 35. Global Vismodegib Sales Share by Type (2023-2028)
Table 36. Global Vismodegib Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Vismodegib Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Vismodegib Revenue Share by Type (2017-2022)
Table 39. Global Vismodegib Revenue Share by Type (2023-2028)
Table 40. Vismodegib Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Vismodegib Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Vismodegib Sales by Application (2017-2022) & (Tons)
Table 43. Global Vismodegib Sales by Application (2023-2028) & (Tons)
Table 44. Global Vismodegib Sales Share by Application (2017-2022)
Table 45. Global Vismodegib Sales Share by Application (2023-2028)
Table 46. Global Vismodegib Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Vismodegib Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Vismodegib Revenue Share by Application (2017-2022)
Table 49. Global Vismodegib Revenue Share by Application (2023-2028)
Table 50. Vismodegib Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Vismodegib Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Vismodegib Sales by Type (2017-2022) & (Tons)
Table 53. North America Vismodegib Sales by Type (2023-2028) & (Tons)
Table 54. North America Vismodegib Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Vismodegib Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Vismodegib Sales by Application (2017-2022) & (Tons)
Table 57. North America Vismodegib Sales by Application (2023-2028) & (Tons)
Table 58. North America Vismodegib Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Vismodegib Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Vismodegib Sales by Country (2017-2022) & (Tons)
Table 61. North America Vismodegib Sales by Country (2023-2028) & (Tons)
Table 62. North America Vismodegib Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Vismodegib Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Vismodegib Sales by Type (2017-2022) & (Tons)
Table 65. Europe Vismodegib Sales by Type (2023-2028) & (Tons)
Table 66. Europe Vismodegib Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Vismodegib Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Vismodegib Sales by Application (2017-2022) & (Tons)
Table 69. Europe Vismodegib Sales by Application (2023-2028) & (Tons)
Table 70. Europe Vismodegib Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Vismodegib Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Vismodegib Sales by Country (2017-2022) & (Tons)
Table 73. Europe Vismodegib Sales by Country (2023-2028) & (Tons)
Table 74. Europe Vismodegib Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Vismodegib Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Vismodegib Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Vismodegib Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Vismodegib Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Vismodegib Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Vismodegib Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Vismodegib Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Vismodegib Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Vismodegib Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Vismodegib Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Vismodegib Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Vismodegib Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Vismodegib Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Vismodegib Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Vismodegib Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Vismodegib Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Vismodegib Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Vismodegib Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Vismodegib Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Vismodegib Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Vismodegib Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Vismodegib Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Vismodegib Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Vismodegib Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Vismodegib Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Vismodegib Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Vismodegib Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Vismodegib Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Vismodegib Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Vismodegib Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Vismodegib Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Vismodegib Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Vismodegib Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Vismodegib Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Vismodegib Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Vismodegib Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Vismodegib Revenue by Country (2023-2028) & (US$ Million)
Table 112. Fermion Corporation Information
Table 113. Fermion Description and Major Businesses
Table 114. Fermion Vismodegib Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Fermion Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Fermion Recent Development
Table 117. Roche Corporation Information
Table 118. Roche Description and Major Businesses
Table 119. Roche Vismodegib Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Roche Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Roche Recent Development
Table 122. Symbio Generrics Corporation Information
Table 123. Symbio Generrics Description and Major Businesses
Table 124. Symbio Generrics Vismodegib Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Symbio Generrics Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Symbio Generrics Recent Development
Table 127. Hetero Corporation Information
Table 128. Hetero Description and Major Businesses
Table 129. Hetero Vismodegib Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Hetero Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Hetero Recent Development
Table 132. Southeast Pharmaceuticals Corporation Information
Table 133. Southeast Pharmaceuticals Description and Major Businesses
Table 134. Southeast Pharmaceuticals Vismodegib Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Southeast Pharmaceuticals Vismodegib Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Southeast Pharmaceuticals Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Vismodegib Distributors List
Table 140. Vismodegib Customers List
Table 141. Vismodegib Market Trends
Table 142. Vismodegib Market Drivers
Table 143. Vismodegib Market Challenges
Table 144. Vismodegib Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Vismodegib Product Picture
Figure 2. Global Vismodegib Market Share by Type in 2021 & 2028
Figure 3. Purity ≥99% Product Picture
Figure 4. Purity ≥99.5% Product Picture
Figure 5. Global Vismodegib Market Share by Application in 2021 & 2028
Figure 6. Pharmaceutical
Figure 7. Research Reagents
Figure 8. Other
Figure 9. Vismodegib Report Years Considered
Figure 10. Global Vismodegib Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Vismodegib Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Vismodegib Production Market Share by Region (2017-2022)
Figure 13. Global Vismodegib Production Market Share by Region (2023-2028)
Figure 14. Vismodegib Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Vismodegib Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Vismodegib Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Vismodegib Production Growth Rate in India (2017-2028) & (Tons)
Figure 18. Global Vismodegib Sales 2017-2028 (Tons)
Figure 19. Global Vismodegib Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Vismodegib Revenue 2017-2028 (US$ Million)
Figure 21. Global Vismodegib Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Vismodegib Sales Market Share by Region (2017-2022)
Figure 23. Global Vismodegib Sales Market Share by Region (2023-2028)
Figure 24. North America Vismodegib Sales YoY (2017-2028) & (Tons)
Figure 25. North America Vismodegib Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Vismodegib Sales YoY (2017-2028) & (Tons)
Figure 27. Europe Vismodegib Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Vismodegib Sales YoY (2017-2028) & (Tons)
Figure 29. Asia-Pacific Vismodegib Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Vismodegib Sales YoY (2017-2028) & (Tons)
Figure 31. Latin America Vismodegib Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Vismodegib Sales YoY (2017-2028) & (Tons)
Figure 33. Middle East & Africa Vismodegib Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Vismodegib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Vismodegib in the World: Market Share by Vismodegib Revenue in 2021
Figure 36. Vismodegib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Vismodegib Sales Market Share by Type (2017-2028)
Figure 38. Global Vismodegib Revenue Market Share by Type (2017-2028)
Figure 39. Global Vismodegib Sales Market Share by Application (2017-2028)
Figure 40. Global Vismodegib Revenue Market Share by Application (2017-2028)
Figure 41. North America Vismodegib Sales Market Share by Type (2017-2028)
Figure 42. North America Vismodegib Revenue Market Share by Type (2017-2028)
Figure 43. North America Vismodegib Sales Market Share by Application (2017-2028)
Figure 44. North America Vismodegib Revenue Market Share by Application (2017-2028)
Figure 45. North America Vismodegib Sales Share by Country (2017-2028)
Figure 46. North America Vismodegib Revenue Share by Country (2017-2028)
Figure 47. United States Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Vismodegib Sales Market Share by Type (2017-2028)
Figure 50. Europe Vismodegib Revenue Market Share by Type (2017-2028)
Figure 51. Europe Vismodegib Sales Market Share by Application (2017-2028)
Figure 52. Europe Vismodegib Revenue Market Share by Application (2017-2028)
Figure 53. Europe Vismodegib Sales Share by Country (2017-2028)
Figure 54. Europe Vismodegib Revenue Share by Country (2017-2028)
Figure 55. Germany Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 56. France Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Vismodegib Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Vismodegib Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Vismodegib Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Vismodegib Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Vismodegib Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Vismodegib Revenue Share by Region (2017-2028)
Figure 66. China Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 69. India Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Vismodegib Sales Market Share by Type (2017-2028)
Figure 76. Latin America Vismodegib Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Vismodegib Sales Market Share by Application (2017-2028)
Figure 78. Latin America Vismodegib Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Vismodegib Sales Share by Country (2017-2028)
Figure 80. Latin America Vismodegib Revenue Share by Country (2017-2028)
Figure 81. Mexico Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Vismodegib Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Vismodegib Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Vismodegib Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Vismodegib Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Vismodegib Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Vismodegib Revenue Share by Country (2017-2028)
Figure 90. Turkey Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Vismodegib Revenue (2017-2028) & (US$ Million)
Figure 93. Vismodegib Value Chain
Figure 94. Vismodegib Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed


★調査レポート[ビスモデギブの世界市場インサイト・予測（～2028年）] (コード：QY22JLX02855)販売に関する免責事項を必ずご確認ください。
★調査レポート[ビスモデギブの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • グリセリンエトキシレートの世界市場インサイト・予測（～2028年）
  • エルシルアミンの世界市場インサイト・予測（～2028年）
  • 高純度MDIの世界市場インサイト・予測（～2028年）
  • 5-クロロバレロニトリルの世界市場インサイト・予測（～2028年）
  • シリコーンプロファイラーの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆